Update
$Genelux (GNLX.US)$ Reuters· 1 min ago
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy With Olvi-Vec in Non-Small Cell Lung Cancer
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy With Olvi-Vec in Non-Small Cell Lung Cancer
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment